2019
GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA
Otvos B, Grabowski M, Alban T, Golubovsky J, Neumann C, Rabjlenovic A, Bayik D, Lauko A, Bucala R, Vogelbaum M, Lathia J. GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA. Neuro-Oncology 2019, 21: vi103-vi103. PMCID: PMC6847914, DOI: 10.1093/neuonc/noz175.428.Peer-Reviewed Original ResearchProgression-free survivalShorter progression-free survivalMacrophage migration inhibitory factorOverall survivalGBM patientsMIF expressionSingle nucleotide polymorphismsRisk factorsSNP statusGBM developmentKarnofsky performance statusWorse overall prognosisShorter overall survivalImmune suppressive microenvironmentMigration inhibitory factorGBM cancer stem cellsCancer stem cellsMGMT methylation statusGenomic risk factorsFree survivalOverall prognosisPerformance statusSuppressor cellsCare therapyPrognostic factors
2006
The Role of Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients.
Lin S, Fultz S, Justice A, Bucala R, Vanasse K, Berliner N. The Role of Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients. Blood 2006, 108: 1254. DOI: 10.1182/blood.v108.11.1254.1254.Peer-Reviewed Original ResearchDevelopment of anemiaVeterans Aging Cohort StudySetting of HIVMIF expressionMIF polymorphismsMacrocytic anemiaCox proportional hazards modelMacrophage migration inhibitory factor geneMarkers of morbidityMIF gene polymorphismsEtiology of anemiaIndependent risk factorCo-morbid conditionsCo-morbid diseasesAging Cohort StudySingle nucleotide polymorphismsSeverity of manifestationsRelease of TNFProportional hazards modelCytokine gene expressionMean corpuscular volumeType/severityVariety of illnessesCD4 countCohort study